Zobrazeno 1 - 10
of 315
pro vyhledávání: '"Anais, Malpica"'
Autor:
Kwong-Kwok Wong, Nicholas W. Bateman, Chun Wai Ng, Yvonne T. M. Tsang, Charlotte S. Sun, Joseph Celestino, Tri V. Nguyen, Anais Malpica, R. Tyler Hillman, Jianhua Zhang, P. Andrew Futreal, Christine Rojas, Kelly A. Conrads, Brian L. Hood, Clifton L. Dalgard, Matthew D. Wilkerson, Neil T. Phippen, Thomas P. Conrads, George L. Maxwell, Anil K. Sood, David M. Gershenson
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-15 (2022)
Abstract Background Low-grade serous ovarian cancer (LGSOC) is a rare disease that occurs more frequently in younger women than those with high-grade disease. The current treatment is suboptimal and a better understanding of the molecular pathogenesi
Externí odkaz:
https://doaj.org/article/3d3ade2fb20a4c199fb227538f7a10f6
Autor:
Elizabeth D. Euscher, Mario L. Marques-Piubelli, Preetha Ramalingam, Ignacio Wistuba, Barrett C. Lawson, Michael Frumovitz, Anais Malpica
Publikováno v:
American Journal of Surgical Pathology. 47:635-648
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05fdf8dce778ec408357f15d58aa02f7
https://doi.org/10.1097/pas.0000000000002039
https://doi.org/10.1097/pas.0000000000002039
Autor:
David M. Gershenson, Lauren P. Cobb, Shannon N. Westin, Yingao Zhang, Amir Jazaeri, Anais Malpica, Charlotte C. Sun
Publikováno v:
Gynecologic Oncology. 167:139-145
The purpose of the present study is to describe a cohort who received contemporary primary treatment for stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC), including patient characteristics and determinants of relapse and disease-free su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10994a8464d53f0e202f8693bad867fd
https://doi.org/10.1016/j.ygyno.2022.09.005
https://doi.org/10.1016/j.ygyno.2022.09.005
Autor:
Elvio G. Silva, Barrett C. Lawson, Preetha Ramalingam, Jinsong Liu, Ahmed Shehabeldin, Mario L. Marques-Piubelli, Anais Malpica
Publikováno v:
Human Pathology. 127:136-145
Ovarian serous neoplasms are thought to arise from the fallopian tube or from the ovarian surface epithelium. The possibility of a third pathway-involving the mesenchymal-epithelial transition and mimicking the formation of the Müllerian duct-arose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f8bf5acb8ac85e5e4a7719ca38f633f
https://doi.org/10.1016/j.humpath.2022.04.008
https://doi.org/10.1016/j.humpath.2022.04.008
Autor:
Daniel M. Halperin, Gauri R. Varadhachary, James C. Yao, Scott E. Woodman, Keith F. Fournier, Scott Kopetz, Ajaykumar C. Morani, Walter C. Darbonne, Katja Schulze, Shannon Dervin, Cindy Yun, Edward McKenna, Patricia Cortazar, Patrick Hwu, Armeen Mahvash, Anuj Verma, Pamela Villalobos, Honglei Chen, Edwin R. Parra Cuentas, Luisa M. Solis Soto, Dipen M. Maru, Andrew P. Futreal, Ignacio I. Wistuba, Paul F. Mansfield, Christopher P. Scally, Richard E. Royal, Seema Prasad, Anais Malpica, Szu-Chin Fu, Mark Knafl, Anneleis F. Willett, Michael J. Overman, Suyu Liu, Kanwal Raghav
Malignant peritoneal mesothelioma (MPeM) is a rare but aggressive malignancy with limited treatment options. VEGF inhibition enhances efficacy of immune-checkpoint inhibitors by reworking the immunosuppressive tumor milieu. Efficacy and safety of com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::810c1697e03dca3033be01a2d214aa5c
https://doi.org/10.1158/2159-8290.c.6549433.v1
https://doi.org/10.1158/2159-8290.c.6549433.v1
Autor:
Anais, Malpica, Elizabeth D, Euscher, Mario L, Marques-Piubelli, Roberto N, Miranda, Kanwal P, Raghav, Keith F, Fournier, Preetha, Ramalingam
Publikováno v:
American Journal of Surgical Pathology. 46:1352-1363
Localized malignant peritoneal mesothelioma is a rare tumor with limited information in the literature. In this study, we present our experience with 18 cases seen in our hospital over a period of 43 years (1978 to 2021). Patients' median age was 55
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecb3621e885dcc7c8b7d983cc1789843
https://doi.org/10.1097/pas.0000000000001924
https://doi.org/10.1097/pas.0000000000001924
Autor:
Michael T. Tetzlaff, Victor G. Prieto, Anais Malpica, Michael A. Davies, Jeffrey E. Gershenwald, Michael Frumovitz, Charles F. Levenback, Merrick I. Ross, Doina Ivan, Phyu P. Aung, Carlos A. Torres-Cabala, Jin Piao, Jing Ning, Jonathan L. Curry, Priyadharsini Nagarajan
TT, tumor thickness; NR, not reported * Includes vulvar (n=14) and vaginal (n=7) melanomas £ Includes vulvar (n=16), vaginal (n=1) and cervical (n=1) melanomas ¥ Includes vulvar (n=61), vaginal (n=15), urethral (n=5) and cervical (n=4) melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1daff840917a55534ec13bd76ba1d1ce
https://doi.org/10.1158/1078-0432.22465739.v1
https://doi.org/10.1158/1078-0432.22465739.v1
Autor:
Michael T. Tetzlaff, Victor G. Prieto, Anais Malpica, Michael A. Davies, Jeffrey E. Gershenwald, Michael Frumovitz, Charles F. Levenback, Merrick I. Ross, Doina Ivan, Phyu P. Aung, Carlos A. Torres-Cabala, Jin Piao, Jing Ning, Jonathan L. Curry, Priyadharsini Nagarajan
(A, B, C) We first assigned patients with PVM to a T-category according to the AJCC for PCM (7th Edition). (A) Shows the AJCC schema and the number of patients assigned to each category. (B) Kaplan Meier DSS curves for patients stratified by AJCC T-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::539ec061d1fc60ed7906af4126a76095
https://doi.org/10.1158/1078-0432.22465745
https://doi.org/10.1158/1078-0432.22465745
Autor:
Michael T. Tetzlaff, Victor G. Prieto, Anais Malpica, Michael A. Davies, Jeffrey E. Gershenwald, Michael Frumovitz, Charles F. Levenback, Merrick I. Ross, Doina Ivan, Phyu P. Aung, Carlos A. Torres-Cabala, Jin Piao, Jing Ning, Jonathan L. Curry, Priyadharsini Nagarajan
Supplemental Figure 1. Correlation between dermal mitotic rate and patient survival. Kaplan-Meier estimate of (A) overall survival and (B) disease-specific survival based on dermal mitotic rate (mitotic figures/mm2). Supplemental Figure 2. Derivation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d666075c6bd55b72d467b5e02f58e24
https://doi.org/10.1158/1078-0432.22465742
https://doi.org/10.1158/1078-0432.22465742
Autor:
Michael T. Tetzlaff, Victor G. Prieto, Anais Malpica, Michael A. Davies, Jeffrey E. Gershenwald, Michael Frumovitz, Charles F. Levenback, Merrick I. Ross, Doina Ivan, Phyu P. Aung, Carlos A. Torres-Cabala, Jin Piao, Jing Ning, Jonathan L. Curry, Priyadharsini Nagarajan
Kaplan-Meier estimate of (A) overall survival and (B) disease-specific survival based on dermal mitotic rate (mitotic figures/mm2).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a06ad243a029095060f3e749de8dd11
https://doi.org/10.1158/1078-0432.22465748
https://doi.org/10.1158/1078-0432.22465748